✦ LIBER ✦

Duration and reproducibility of initial hemodynamic effects of flosequinan in patients with congestive heart failure

✍ Scribed by G. L. Bartels; W. J. Remme; A. C. P. Wiesfeld; F. J. Kok; M. P. Look; X. H. Krauss; H. A. C. M. Kruyssen

Publisher: Springer US
Year: 1990
Tongue: English
Weight: 595 KB
Volume: 4
Category: Article
ISSN: 0920-3206
DOI: 10.1007/bf01856558

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of flosequinan in elder

Pharmacokinetics of flosequinan in elderly patients with chronic congestive heart failure

✍ M. Sakai; S. Ohkawa; T. Kaku; K. Kuboki; K. Chida; T. Imai 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 293 KB

Exercise capacity, hemodynamic, and neur

Exercise capacity, hemodynamic, and neurohumoral changes following acute and chronic administration of flosequinan in chronic congestive heart failure

✍ Günter A. J. Riegger; Heinz Kahles; Andreas Wagner; Eckhard P. Kromer; Dietma El 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 571 KB

Peripheral hemodynamic effects of ibopam

Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study

✍ C. Longhini; L. Ansani; G. F. Musacci; S. Aggio; E. Baracca; T. Toselli; P. Ghir 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 282 KB

A comparison of the effects of captopril

A comparison of the effects of captopril and flosequinan in patients with severe heart failure

✍ A. J. Cowley; R. D. Wynne; A. Swami; J. Birkhead; A. Skene; J. R. Hampton 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 542 KB

Angiotensin converting enzyme inhibitors have greatly improved the treatment of patients with chronic heart failure but they are not effective in all patients, and their use may be limited by side effects. There is, therefore, a need to investigate new drugs and to compare their efficacy with angiot

Acute haemodynamic and neurohumoral effe

Acute haemodynamic and neurohumoral effects of intravenous nisoldipine in patients with severe congestive heart failure

✍ H. H. Erlemeier; W. Kupper; W. Bleifeld 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 473 KB

Twenty patients (5 females, 15 males) with severe heart failure (NYHA IV), due to coronary artery disease in 14, and congestive cardiomyopathy in 6, received an intravenous bolus of the calcium blocker nisoldipine 0.2 mg followed by a continuous infusion of 0.2 micrograms.kg-1.min-1. Haemodynamic me

The central haemodynamic effects of a si

The central haemodynamic effects of a single intravenous dose of flosequinan in patients with severe heart failure

✍ H. Markus; A. J. Cowley 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 332 KB

The acute central haemodynamic and neuroendocrine effects of intravenous flosequinan were studied in a group of 10 patients with severe heart failure. Flosequinan improved cardiac output by a maximum of 1.59 l.min-1, it reduced pulmonary capillary wedge pressure by 11.9 mm Hg and it also caused a re